Clinical Trials
10
Active:1
Completed:0
Trial Phases
1 Phases
Not Applicable:10
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Not Applicable
10 (100.0%)Feasibility Study of the DragonFire for Hypertrophic Obstructive Cardiomyopathy
Not Applicable
Not yet recruiting
- Conditions
- Obstructive Hypertrophic Cardiomyopathy
- First Posted Date
- 2024-04-16
- Last Posted Date
- 2024-04-16
- Lead Sponsor
- Hangzhou Valgen Medtech Co., Ltd
- Target Recruit Count
- 10
- Registration Number
- NCT06368037
- Locations
- 🇨🇳
Northern Theater Command General Hospital of the Chinese People's Liberation Army, Shenyang, China
Feasibility Study of the DragonFire for Hypertrophic Obstructive Cardiomyopathy
Not Applicable
Active, not recruiting
- Conditions
- Obstructive Hypertrophic Cardiomyopathy
- First Posted Date
- 2024-01-18
- Last Posted Date
- 2024-01-18
- Lead Sponsor
- Hangzhou Valgen Medtech Co., Ltd
- Target Recruit Count
- 10
- Registration Number
- NCT06211595
- Locations
- 🇨🇳
The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
DragonFly EU Pivotal Study
Not Applicable
Not yet recruiting
- Conditions
- Mitral Valve Insufficiency
- First Posted Date
- 2023-07-03
- Last Posted Date
- 2023-07-11
- Lead Sponsor
- Hangzhou Valgen Medtech Co., Ltd
- Target Recruit Count
- 168
- Registration Number
- NCT05927441
Feasibility Study of the DragonFly-T System for Severe Tricuspid Regurgitation
Not Applicable
Recruiting
- Conditions
- Tricuspid Regurgitation
- First Posted Date
- 2023-01-04
- Last Posted Date
- 2023-01-04
- Lead Sponsor
- Hangzhou Valgen Medtech Co., Ltd
- Target Recruit Count
- 10
- Registration Number
- NCT05671640
- Locations
- 🇨🇳
The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation
Not Applicable
Recruiting
- Conditions
- Tricuspid Regurgitation
- Interventions
- Device: DragonFly-T Transcatheter Tricuspid Valve Repair SystemDrug: Medical therapy
- First Posted Date
- 2022-09-27
- Last Posted Date
- 2024-07-19
- Lead Sponsor
- Hangzhou Valgen Medtech Co., Ltd
- Target Recruit Count
- 236
- Registration Number
- NCT05556460
- Locations
- 🇨🇳
West China Hospital of Sichuan University, Chengdu, Sichuan, China
🇨🇳The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
- Prev
- 1
- 2
- Next
News
No news found